Novartis Investigative Site

Muang, Chiangmai 50200

0 studies enrolling now · 2 studies all time

What they study most

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia, Transfusion-dependent Anemia

Studies at this site

• Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload — Completed
• Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. — Completed